(Q36245700)

English

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

multicenter clinical trial

0 references

0 references

Martin Soubrier

4

object named as

Martin Soubrier

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Daniel Wendling

3

object named as

Daniel Wendling

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Fernando Kemta Lekpa

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cécile Poulain

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Michel De Bandt

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jean Marie Berthelot

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Philippe Gaudin

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Eric Toussirot

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Philippe Goupille

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Thao Pham

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jérémie Sellam

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Rémy Bruckert

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Muriel Paul

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Valérie Farrenq

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pascal Claudepierre

15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Club Rhumatismes et Inflammation

16

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

9 March 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R53

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

1 October 2017

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Abatacept as an option therapy in difficult to treat psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Mixed response to tocilizumab for ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX).

1 reference

https://api.crossref.org/works/10.1186%2FAR3766

21 January 2018

Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

22 September 2018

The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

22 September 2018

Sustained response to anakinra in ankylosing spondylitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446419

22 September 2018

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria of the classification of spondylarthropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of psoriatic arthritis with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term effect of IL-6 inhibition in spondylarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic agents for treating ankylosing spondylitis: beyond TNFα antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/22404969

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36245700&oldid=2198439807"